LH
LABCORP HOLDINGS INC.
-0.25 (-0.08%)324.26USD175K成交股數26.3B市值26.8本益比(近四季)1.8股價營收比+5.8%營收年增(近四季)2026-10-27下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 7 · 3.3M · 6 |
| 其中 10b5-1 計畫賣出 | 4 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 5.6M |
| 近 180 天 淨額 | −5.6M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | 08-18 | ANDERSON KERRII B | Director | S 公開市場賣出(10b5-1) | 3.0K | 318.02 | 954K | 6.6K | SEC |
| 2026-08-11 | 08-12 | Schechter Adam H | President & CEO | S 公開市場賣出(10b5-1) | 4.7K | 320.37 | 1.5M | 103K | SEC |
| 2026-08-04 | 08-06 | Summy Amy B. | EVP, Chief Marketing Officer | S 公開市場賣出 | 924 | 306.74 | 283K | 7.0K | SEC |
| 2026-08-03 | 08-05 | Wilkinson Peter J | SVP, Chief Accounting Officer | S 公開市場賣出 | 82 | 309.22 | 25K | 1.8K | SEC |
| 2026-08-03 | 08-05 | Wilkinson Peter J | SVP, Chief Accounting Officer | S 公開市場賣出 | 1.3K | 309.23 | 414K | 1.8K | SEC |
| 2026-08-03 | 08-05 | Wilkinson Peter J | SVP, Chief Accounting Officer | M 選擇權執行 | 1.3K | 209.25 | 280K | 3.1K | SEC |
| 2026-07-02 | 07-06 | Kyle Kathryn W | EVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 92 | 286.19 | 26K | 3.9K | SEC |
| 2026-07-02 | 07-06 | Vaughn Bryan T | EVP and President, Diagnostics | S 公開市場賣出(10b5-1) | 234 | 286.19 | 67K | 6.7K | SEC |
| 2026-07-01 | 07-06 | Kyle Kathryn W | EVP, Chief Legal Officer | M 選擇權執行 | 256 | – | – | 4.1K | SEC |
| 2026-07-01 | 07-06 | Kyle Kathryn W | EVP, Chief Legal Officer | F 繳稅扣股 | 73 | 283.88 | 21K | 4.0K | SEC |
| 2026-07-01 | 07-06 | Vaughn Bryan T | EVP and President, Diagnostics | F 繳稅扣股 | 93 | 283.88 | 26K | 7.0K | SEC |
| 2026-07-01 | 07-06 | Vaughn Bryan T | EVP and President, Diagnostics | M 選擇權執行 | 327 | – | – | 7.1K | SEC |
| 2026-06-08 | 06-10 | Kyle Kathryn W | EVP, Chief Legal Officer | S 公開市場賣出(10b5-1) | 762 | 263.89 | 201K | 3.8K | SEC |
| 2026-05-11 | 05-13 | Schechter Adam H | President & CEO | S 公開市場賣出(10b5-1) | 5.9K | 254.50 | 1.5M | 107K | SEC |
| 2026-03-27 | 03-30 | Meltzer Jonathan C | EVP, Operations | S 公開市場賣出(10b5-1) | 839 | 267.05 | 224K | 3.6K | SEC |
| 2026-03-27 | 03-30 | Wilkinson Peter J | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 1.6K | 267.05 | 436K | 1.9K | SEC |
| 2026-03-26 | 03-30 | Wilkinson Peter J | SVP, Chief Accounting Officer | F 繳稅扣股 | 755 | 268.38 | 203K | 3.5K | SEC |
| 2026-03-26 | 03-30 | Vaughn Bryan T | EVP, Diagnostics | F 繳稅扣股 | 451 | 268.38 | 121K | 6.7K | SEC |
| 2026-03-26 | 03-30 | Vaughn Bryan T | EVP, Diagnostics | A 獲配股票 | 1.6K | – | – | 7.2K | SEC |
| 2026-03-26 | 03-30 | van der Vaart Sandra D | EVP, Corporate Affairs | A 獲配股票 | 6.4K | – | – | 9.0K | SEC |
| 2026-03-26 | 03-30 | Summy Amy B. | EVP, Chief Marketing Officer | A 獲配股票 | 4.0K | – | – | 9.7K | SEC |
| 2026-03-26 | 03-30 | Summy Amy B. | EVP, Chief Marketing Officer | F 繳稅扣股 | 1.8K | 268.38 | 493K | 7.9K | SEC |
| 2026-03-26 | 03-30 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F 繳稅扣股 | 481 | 268.38 | 129K | 4.9K | SEC |
| 2026-03-26 | 03-30 | Oyegunwa Akinbolade | EVP, CIO & CTO | A 獲配股票 | 1.3K | – | – | 5.4K | SEC |
| 2026-03-26 | 03-30 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | A 獲配股票 | 1.2K | – | – | 5.3K | SEC |
| 2026-03-26 | 03-30 | Wilkinson Peter J | SVP, Chief Accounting Officer | A 獲配股票 | 2.4K | – | – | 4.2K | SEC |
| 2026-03-26 | 03-30 | GRAHAM ANITA Z | EVP, CHRO | F 繳稅扣股 | 2.9K | 268.38 | 773K | 5.2K | SEC |
| 2026-03-26 | 03-30 | GRAHAM ANITA Z | EVP, CHRO | A 獲配股票 | 6.6K | – | – | 8.1K | SEC |
| 2026-03-26 | 03-30 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F 繳稅扣股 | 1.5K | 268.38 | 394K | 12.7K | SEC |
| 2026-03-26 | 03-30 | van der Vaart Sandra D | EVP, Corporate Affairs | F 繳稅扣股 | 2.7K | 268.38 | 731K | 6.2K | SEC |
| 2026-03-26 | 03-30 | Meltzer Jonathan C | EVP, Operations | F 繳稅扣股 | 711 | 268.38 | 191K | 4.5K | SEC |
| 2026-03-26 | 03-30 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A 獲配股票 | 3.0K | – | – | 14.1K | SEC |
| 2026-03-26 | 03-30 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F 繳稅扣股 | 863 | 268.38 | 232K | 36.5K | SEC |
| 2026-03-26 | 03-30 | Kyle Kathryn W | EVP, Chief Legal Officer | F 繳稅扣股 | 451 | 268.38 | 121K | 4.6K | SEC |
| 2026-03-26 | 03-30 | Meltzer Jonathan C | EVP, Operations | A 獲配股票 | 2.4K | – | – | 5.2K | SEC |
| 2026-03-26 | 03-30 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F 繳稅扣股 | 4.0K | 268.38 | 1.1M | 35.4K | SEC |
| 2026-03-26 | 03-30 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F 繳稅扣股 | 4.6K | 268.38 | 1.2M | 11.2K | SEC |
| 2026-03-26 | 03-30 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A 獲配股票 | 2.0K | – | – | 37.4K | SEC |
| 2026-03-26 | 03-30 | Schroeder Mark S | EVP, Pres Diagnostics & COO | A 獲配股票 | 9.3K | – | – | 15.8K | SEC |
| 2026-03-26 | 03-30 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | A 獲配股票 | 9.3K | – | – | 39.4K | SEC |
| 2026-03-26 | 03-30 | Kyle Kathryn W | EVP, Chief Legal Officer | A 獲配股票 | 1.6K | – | – | 5.0K | SEC |
| 2026-03-26 | 03-30 | Schechter Adam H | President & CEO | A 獲配股票 | 58.5K | – | – | 139K | SEC |
| 2026-03-26 | 03-30 | Oyegunwa Akinbolade | EVP, CIO & CTO | F 繳稅扣股 | 382 | 268.38 | 103K | 5.1K | SEC |
| 2026-03-26 | 03-30 | Schechter Adam H | President & CEO | F 繳稅扣股 | 26.1K | 268.38 | 7.0M | 113K | SEC |
| 2026-03-03 | 03-05 | Schechter Adam H | President & CEO | S 公開市場賣出 | 8.7K | 279.96 | 2.4M | 80.8K | SEC |
| 2026-02-27 | 03-03 | van der Vaart Sandra D | EVP, Corporate Affairs | S 公開市場賣出 | 548 | 284.91 | 156K | 2.6K | SEC |
| 2026-02-24 | 02-26 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | S 公開市場賣出 | 1.5K | 286.31 | 429K | 30.1K | SEC |
| 2026-02-19 | 02-23 | Wilkinson Peter J | SVP, Chief Accounting Officer | S 公開市場賣出(10b5-1) | 666 | 277.94 | 185K | 1.9K | SEC |
| 2026-02-12 | 02-13 | Meltzer Jonathan C | EVP, Operations | S 公開市場賣出(10b5-1) | 87 | 290.42 | 25K | 2.8K | SEC |
| 2026-02-11 | 02-13 | GRAHAM ANITA Z | EVP, CHRO | F 繳稅扣股 | 109 | 289.89 | 32K | 1.5K | SEC |
| 2026-02-11 | 02-13 | GRAHAM ANITA Z | EVP, CHRO | M 選擇權執行 | 356 | – | – | 1.6K | SEC |
| 2026-02-11 | 02-13 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | F 繳稅扣股 | 211 | 289.89 | 61K | 31.6K | SEC |
| 2026-02-11 | 02-13 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | F 繳稅扣股 | 138 | 289.89 | 40K | 4.1K | SEC |
| 2026-02-11 | 02-13 | Bailey Megan D. | EVP, Pres, Central Labs & Intl | M 選擇權執行 | 403 | – | – | 4.3K | SEC |
| 2026-02-11 | 02-13 | Rothman Paul | Director | M 選擇權執行 | 897 | – | – | 2.6K | SEC |
| 2026-02-11 | 02-13 | Wengel Kathryn E | Director | M 選擇權執行 | 897 | – | – | 4.1K | SEC |
| 2026-02-11 | 02-13 | Parham Richelle P | Director | M 選擇權執行 | 897 | – | – | 3.4K | SEC |
| 2026-02-11 | 02-13 | Caveney Brian J | EVP, Pres of ED, CMO & CSO | M 選擇權執行 | 740 | – | – | 31.8K | SEC |
| 2026-02-11 | 02-13 | NEUPERT PETER M | Director | M 選擇權執行 | 897 | – | – | 13.8K | SEC |
| 2026-02-11 | 02-13 | Kong Garheng | Director | M 選擇權執行 | 897 | – | – | 13.7K | SEC |
| 2026-02-11 | 02-13 | Kliphouse Kirsten Marie | Director | M 選擇權執行 | 897 | – | – | 3.2K | SEC |
| 2026-02-11 | 02-13 | Kyle Kathryn W | EVP, Chief Legal Officer | M 選擇權執行 | 216 | – | – | 3.5K | SEC |
| 2026-02-11 | 02-13 | Davis Jeffrey A. | Director | M 選擇權執行 | 897 | – | – | 5.5K | SEC |
| 2026-02-11 | 02-13 | Wang Julia Aijun | Chief Financial Officer, EVP | F 繳稅扣股 | 245 | 289.89 | 71K | 1.8K | SEC |
| 2026-02-11 | 02-13 | Vaughn Bryan T | EVP, Diagnostics | F 繳稅扣股 | 93 | 289.89 | 27K | 5.6K | SEC |
| 2026-02-11 | 02-13 | Vaughn Bryan T | EVP, Diagnostics | M 選擇權執行 | 323 | – | – | 5.7K | SEC |
| 2026-02-11 | 02-13 | van der Vaart Sandra D | EVP, Corporate Affairs | F 繳稅扣股 | 99 | 289.89 | 29K | 3.1K | SEC |
| 2026-02-11 | 02-13 | Schroeder Mark S | EVP, Pres Diagnostics & COO | F 繳稅扣股 | 259 | 289.89 | 75K | 6.5K | SEC |
| 2026-02-11 | 02-13 | Schroeder Mark S | EVP, Pres Diagnostics & COO | M 選擇權執行 | 806 | – | – | 6.7K | SEC |
| 2026-02-11 | 02-13 | Schechter Adam H | President & CEO | F 繳稅扣股 | 1.5K | 289.89 | 441K | 89.5K | SEC |
| 2026-02-11 | 02-13 | Schechter Adam H | President & CEO | M 選擇權執行 | 3.7K | – | – | 91.0K | SEC |
| 2026-02-11 | 02-13 | Schechter Adam H | President & CEO | S 公開市場賣出(10b5-1) | 5.3K | 284.38 | 1.5M | 87.3K | SEC |
| 2026-02-11 | 02-13 | Oyegunwa Akinbolade | EVP, CIO & CTO | F 繳稅扣股 | 68 | 289.89 | 20K | 4.1K | SEC |
| 2026-02-11 | 02-13 | van der Vaart Sandra D | EVP, Corporate Affairs | M 選擇權執行 | 376 | – | – | 3.2K | SEC |
| 2026-02-11 | 02-13 | Oyegunwa Akinbolade | EVP, CIO & CTO | M 選擇權執行 | 230 | – | – | 4.2K | SEC |
| 2026-02-11 | 02-13 | Meltzer Jonathan C | EVP, Operations | F 繳稅扣股 | 70 | 289.89 | 20K | 2.9K | SEC |
| 2026-02-11 | 02-13 | Meltzer Jonathan C | EVP, Operations | M 選擇權執行 | 243 | – | – | 2.9K | SEC |
| 2026-02-11 | 02-13 | Wang Julia Aijun | Chief Financial Officer, EVP | M 選擇權執行 | 860 | – | – | 2.1K | SEC |
| 2026-02-11 | 02-13 | Kyle Kathryn W | EVP, Chief Legal Officer | F 繳稅扣股 | 62 | 289.89 | 18K | 3.4K | SEC |
| 2026-02-11 | 02-13 | ANDERSON KERRII B | Director | M 選擇權執行 | 897 | – | – | 9.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.6M | 1.8B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.4M | 1.5B | 新進 | 新進 |
| VICTORY CAPITAL MANAGEMENT INC | 4.8M | 1.4B | 新進 | 新進 |
| STATE STREET CORP | 3.9M | 1.1B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.7M | 1.0B | 新進 | 新進 |
| Boston Partners | 3.1M | 854M | 新進 | 新進 |
| Allspring Global Investments Holdings, LLC | 2.2M | 635M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2M | 610M | 新進 | 新進 |
| Select Equity Group, L.P. | 2.0M | 555M | 新進 | 新進 |
| FMR LLC | 1.9M | 533M | 新進 | 新進 |
| MORGAN STANLEY | 1.6M | 451M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.4M | 383M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 1.3M | 355M | 新進 | 新進 |
| Invesco Ltd. | 1.2M | 347M | 新進 | 新進 |
| NORDEA INVESTMENT MANAGEMENT AB | 916K | 255M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 887K | 248M | 新進 | 新進 |
| NORTHERN TRUST CORP | 883K | 247M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 856K | 240M | 新進 | 新進 |
| AMERICAN CENTURY COMPANIES INC | 845K | 237M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 812K | 227M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 810K | 227M | 新進 | 新進 |
| ROYAL BANK OF CANADA | 808K | 226M | 新進 | 新進 |
| Navera Investment Management Ltd. | 782K | 219M | 新進 | 新進 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 742K | 208M | 新進 | 新進 |
| COOKE & BIELER LP | 669K | 187M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 1,045 +22 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1045 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 79.5M · 98.0% |
| 合計季末市值 | 21.1B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.1M |
|---|---|
| 與上期比 | +8.5% |
| 佔流通股數 | 2.59% |
| 日均成交量 | 660K |
| 回補天數 | 3.2 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.1M | +8.5% | 2.59% | 660K | 3.2 |
| 2026-08-14 | 1.9M | -7.5% | 2.39% | 505K | 3.8 |
| 2026-07-31 | 2.1M | -23.1% | 2.58% | 959K | 2.2 |
| 2026-07-15 | 2.7M | -3.8% | 3.36% | 575K | 4.7 |
| 2026-06-30 | 2.8M | -13.3% | 3.49% | 744K | 3.8 |
| 2026-06-15 | 3.3M | -4.7% | 4.03% | 545K | 6.0 |
| 2026-05-29 | 3.4M | +1.7% | 4.23% | 589K | 5.8 |
| 2026-05-15 | 3.4M | +6.8% | 4.15% | 718K | 4.7 |
| 2026-04-30 | 3.2M | -2.5% | 3.89% | 767K | 4.1 |
| 2026-04-15 | 3.2M | +1.4% | 3.99% | 540K | 6.0 |
| 2026-03-31 | 3.2M | +6.7% | 3.94% | 586K | 5.5 |
| 2026-03-13 | 3.0M | -6.5% | 3.69% | 505K | 5.9 |
| 2026-02-27 | 3.2M | +6.0% | 3.95% | 826K | 3.9 |
| 2026-02-13 | 3.0M | -5.4% | 3.72% | 724K | 4.2 |
| 2026-01-30 | 3.2M | +5.2% | 3.94% | 787K | 4.1 |
| 2026-01-15 | 3.0M | -2.6% | 3.74% | 816K | 3.7 |
| 2025-12-31 | 3.1M | -1.2% | 3.84% | 638K | 4.9 |
| 2025-12-15 | 3.2M | +1.2% | 3.89% | 613K | 5.1 |
| 2025-11-28 | 3.1M | -3.0% | 3.84% | 744K | 4.2 |
| 2025-11-14 | 3.2M | +19.6% | 3.96% | 1.3M | 2.5 |
| 2025-10-31 | 2.7M | +10.1% | 3.31% | 973K | 2.8 |
| 2025-10-15 | 2.4M | -2.8% | 3.01% | 571K | 4.3 |
| 2025-09-30 | 2.5M | +0.6% | 3.09% | 503K | 5.0 |
| 2025-09-15 | 2.5M | -9.4% | 3.08% | 432K | 5.8 |
| 2025-08-29 | 2.8M | +2.9% | 3.40% | 478K | 5.8 |
| 2025-08-15 | 2.7M | -2.6% | 3.30% | 503K | 5.3 |